Within the last several years, the FDA has approved mifepristone (Korlym) and pasireotide (Signifor) for the treatment of Cushing’s and recently issued new warnings for  ketoconazole.

To see the full statement from the FDA on ketoconazole, click here.

To read a Doctor’s Article discussing all of these medications, click here.

For additional information on the approved medications, see the manufacturer’s websites below.

Mifepristone (Korlym)
Pasireotide (Signifor)

Please note that CSRF does not engage in the practice of medicine, endorse any particular commercial products, doctors, surgeons, medications, treatment, or techniques.